26Aug
Financial Daily Dose 8.26.2019 | Top Story: Amgen to Pay More Than $13 Billion for Otezla
Amgen will pay $13.4 billion in cash to buy psoriasis treatment Otezla, a deal that will “pave the way for Bristol-Myers Squibb to complete its acquisition of Celgene” by addressing “regulatory concerns over their union”....
By:
Robins Kaplan LLP
Related
On June 24, 2020, in Sayers Constr., LLC v. Timberline Constr., Inc., et al., a Florida District Cou...
Read More >
Employee With Disabilities Denied a Reasonable Accommodation and Discharged After Seeking Two Days o...
Read More >
On August 9, 2019, the Department of Labor (“DOL”) issued USERRA Fact Sheet 1, providing guidance ...
Read More >
Charities- New York Attorney General Sues Online Fundraising Platform Over Alleged Failure to Distr...
Read More >
The New Jersey Supreme Court has granted certification and will review the Appellate Division decisi...
Read More >
A new package of pro-employee laws regarding worker misclassification in New Jersey was recently sig...
Read More >